BRO vs WTW
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a mixed health profile with a weak Piotroski F-Score of 4/9, indicating borderline financial stability, and no available Altman Z-Score to assess bankruptcy risk. Despite strong revenue growth of 34.20% and solid profitability metrics like a 27.36% operating margin, earnings have declined YoY by -16.10%, creating a divergence between top-line and bottom-line performance. The stock trades above its Graham Number of $52.48 at $79.18, reflecting a premium valuation supported by growth expectations and sector outperformance in revenue. Analysts concur with a 'hold' recommendation, while insider sentiment is neutral and technical indicators suggest bearish momentum.
WTW presents a dichotomy between strong operational profitability and poor deterministic valuation. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current price of $290.89 trades at a significant premium to both the Graham Number ($175.19) and Intrinsic Value ($113.82). Despite negative YoY revenue and earnings growth, the company maintains a strong ROE of 20.08% and a consistent track record of beating earnings estimates. The outlook is tempered by bearish insider sentiment and a weak technical trend, offsetting the bullish analyst consensus.
Compare Another Pair
Related Comparisons
BRO vs WTW: Head-to-Head Comparison
This page compares Brown & Brown, Inc. (BRO) and Willis Towers Watson Public Limited Company (WTW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.